[go: up one dir, main page]

NO20041060L - Krystaller av hydroksynorefedrinderivat - Google Patents

Krystaller av hydroksynorefedrinderivat

Info

Publication number
NO20041060L
NO20041060L NO20041060A NO20041060A NO20041060L NO 20041060 L NO20041060 L NO 20041060L NO 20041060 A NO20041060 A NO 20041060A NO 20041060 A NO20041060 A NO 20041060A NO 20041060 L NO20041060 L NO 20041060L
Authority
NO
Norway
Prior art keywords
hydroxynorphedrine
crystals
derivative
methylethylüaminoüethylü
dimethylphenoxyüacetate
Prior art date
Application number
NO20041060A
Other languages
English (en)
Other versions
NO328252B1 (no
Inventor
Junichi Sonehara
Satoshi Akahane
Yukihiko Hotei
Hidetoshi Lsawa
Kiyoshi Kasai
Original Assignee
Kissei Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Company filed Critical Kissei Pharmaceutical Company
Publication of NO20041060L publication Critical patent/NO20041060L/no
Publication of NO328252B1 publication Critical patent/NO328252B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20041060A 2001-09-13 2004-03-12 Krystaller av hydroksynorefedrinderivat NO328252B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001277345 2001-09-13
PCT/JP2002/008596 WO2003024916A1 (en) 2001-09-13 2002-08-27 Crystals of hydroxynorephedrine derivative

Publications (2)

Publication Number Publication Date
NO20041060L true NO20041060L (no) 2004-06-11
NO328252B1 NO328252B1 (no) 2010-01-18

Family

ID=19101883

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041060A NO328252B1 (no) 2001-09-13 2004-03-12 Krystaller av hydroksynorefedrinderivat

Country Status (28)

Country Link
US (1) US7208520B2 (no)
EP (1) EP1426355B1 (no)
JP (1) JP4157036B2 (no)
KR (2) KR20080098691A (no)
CN (1) CN1275936C (no)
AT (1) ATE411276T1 (no)
AU (1) AU2002330453B2 (no)
BR (1) BR0212494A (no)
CA (1) CA2458544C (no)
CO (1) CO5560555A2 (no)
CY (1) CY1109409T1 (no)
DE (1) DE60229404D1 (no)
DK (1) DK1426355T3 (no)
EA (1) EA006022B1 (no)
EC (1) ECSP045017A (no)
ES (1) ES2314092T3 (no)
HR (1) HRP20040250A2 (no)
HU (1) HUP0401694A3 (no)
IL (2) IL160681A0 (no)
MX (1) MXPA04002449A (no)
NO (1) NO328252B1 (no)
NZ (1) NZ531602A (no)
PL (1) PL206246B1 (no)
PT (1) PT1426355E (no)
SI (1) SI1426355T1 (no)
UA (1) UA77000C2 (no)
WO (1) WO2003024916A1 (no)
ZA (1) ZA200401757B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
BRPI0409980A (pt) * 2003-05-05 2006-05-09 Kissei Pharmaceutical uso de derivados de ácido fenoxiacético para tratar bexiga hiperativa
DE10351271A1 (de) * 2003-10-31 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz
CA2544100A1 (en) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
WO2005092321A1 (ja) * 2004-03-24 2005-10-06 Kissei Pharmaceutical Co., Ltd. 頻尿または尿失禁の予防または治療用医薬組成物
JP4808613B2 (ja) * 2004-03-24 2011-11-02 キッセイ薬品工業株式会社 頻尿または尿失禁の予防または治療用医薬
ES2291780T3 (es) * 2004-06-28 2008-03-01 Grunenthal Gmbh Formas cristalinas del clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)fenol.
DE102004050952A1 (de) * 2004-10-18 2006-04-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind
JP2008516909A (ja) * 2004-10-18 2008-05-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 前立腺及び下部泌尿生殖路の病気を治療するためのβ−3アゴニストの使用
WO2006045519A1 (en) 2004-10-26 2006-05-04 Kissei Pharmaceutical Co., Ltd. Synthesis of phenoxyacetic acid derivatives
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
US8003694B2 (en) 2005-04-26 2011-08-23 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
CA2605337A1 (en) * 2005-04-26 2006-11-23 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
JP5767103B2 (ja) 2008-05-21 2015-08-19 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY126489A (en) 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP4005729B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JP4005730B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形
JP4005731B2 (ja) 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体の結晶多形

Also Published As

Publication number Publication date
IL160681A0 (en) 2004-08-31
EA200400311A1 (ru) 2004-08-26
US20040242686A1 (en) 2004-12-02
US7208520B2 (en) 2007-04-24
PL367874A1 (en) 2005-03-07
ECSP045017A (es) 2004-09-27
AU2002330453B2 (en) 2008-04-17
EA006022B1 (ru) 2005-08-25
IL160681A (en) 2010-06-16
SI1426355T1 (sl) 2009-02-28
ATE411276T1 (de) 2008-10-15
UA77000C2 (en) 2006-10-16
HK1070051A1 (en) 2005-06-10
PL206246B1 (pl) 2010-07-30
EP1426355A4 (en) 2006-03-29
HUP0401694A2 (hu) 2004-11-29
KR20040044881A (ko) 2004-05-31
PT1426355E (pt) 2008-11-03
JP4157036B2 (ja) 2008-09-24
NZ531602A (en) 2006-01-27
KR100874952B1 (ko) 2008-12-19
MXPA04002449A (es) 2004-07-23
NO328252B1 (no) 2010-01-18
WO2003024916A1 (en) 2003-03-27
CO5560555A2 (es) 2005-09-30
KR20080098691A (ko) 2008-11-11
BR0212494A (pt) 2004-08-24
CA2458544C (en) 2010-08-17
CY1109409T1 (el) 2014-07-02
HUP0401694A3 (en) 2008-03-28
EP1426355B1 (en) 2008-10-15
DK1426355T3 (da) 2009-02-23
ZA200401757B (en) 2005-03-03
JPWO2003024916A1 (ja) 2004-12-24
CN1553890A (zh) 2004-12-08
CA2458544A1 (en) 2003-03-27
HRP20040250A2 (en) 2005-02-28
EP1426355A1 (en) 2004-06-09
DE60229404D1 (de) 2008-11-27
CN1275936C (zh) 2006-09-20
ES2314092T3 (es) 2009-03-16

Similar Documents

Publication Publication Date Title
NO20041060L (no) Krystaller av hydroksynorefedrinderivat
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
EA200601269A1 (ru) Лекарственное средство, содержащее производные фенилпиперазина
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0206955A (pt) Ligantes de receptores de canabinóides
SE0201544D0 (sv) Novel compounds and thier use
DK2017276T3 (da) Phenylcarboxamid-forbindelser til behandling af smerte
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
SE0104333D0 (sv) Therapeutic agents
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
SE0004827D0 (sv) Therapeutic compounds
PL370379A1 (pl) N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose
BR0207307A (pt) Inibidores de glyt-1
BR0116724A (pt) Composto, método de tratamento de um distúrbio neurológico ou de uma doença neurodegenerativa, método de tratamento de dor, composição farmacêutica, uso de um composto, e, processos para a preparação e para a sìntese de um composto
EP1234576A4 (en) REMEDIES FOR FOOD DISORDERS
ITTO20040343A1 (it) Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees